AGIO
Price
$43.29
Change
+$1.20 (+2.85%)
Updated
Oct 24, 04:59 PM (EDT)
Capitalization
2.43B
6 days until earnings call
Intraday Buy/Sell Signals
ELVN
Price
$20.61
Change
+$0.06 (+0.29%)
Updated
Oct 24, 04:59 PM (EDT)
Capitalization
1.21B
13 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

AGIO vs ELVN

Header iconAGIO vs ELVN Comparison
Open Charts AGIO vs ELVNBanner chart's image
Agios Pharmaceuticals
Price$43.29
Change+$1.20 (+2.85%)
Volume$9.13K
Capitalization2.43B
Enliven Therapeutics
Price$20.61
Change+$0.06 (+0.29%)
Volume$3.48K
Capitalization1.21B
AGIO vs ELVN Comparison Chart in %
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGIO vs. ELVN commentary
Oct 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a StrongBuy and ELVN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 24, 2025
Stock price -- (AGIO: $42.09 vs. ELVN: $20.55)
Brand notoriety: AGIO and ELVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 50% vs. ELVN: 118%
Market capitalization -- AGIO: $2.43B vs. ELVN: $1.21B
AGIO [@Biotechnology] is valued at $2.43B. ELVN’s [@Biotechnology] market capitalization is $1.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $108.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 1 FA rating(s) are green whileELVN’s FA Score has 1 green FA rating(s).

  • AGIO’s FA Score: 1 green, 4 red.
  • ELVN’s FA Score: 1 green, 4 red.
According to our system of comparison, AGIO is a better buy in the long-term than ELVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 5 TA indicator(s) are bullish while ELVN’s TA Score has 4 bullish TA indicator(s).

  • AGIO’s TA Score: 5 bullish, 5 bearish.
  • ELVN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AGIO is a better buy in the short-term than ELVN.

Price Growth

AGIO (@Biotechnology) experienced а +1.37% price change this week, while ELVN (@Biotechnology) price change was -5.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.73%. For the same industry, the average monthly price growth was +11.03%, and the average quarterly price growth was +64.77%.

Reported Earning Dates

AGIO is expected to report earnings on Oct 30, 2025.

ELVN is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+0.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGIO($2.43B) has a higher market cap than ELVN($1.21B). AGIO YTD gains are higher at: 28.089 vs. ELVN (-8.667). ELVN has higher annual earnings (EBITDA): -113.93M vs. AGIO (-456.28M). AGIO has more cash in the bank: 939M vs. ELVN (491M). ELVN has less debt than AGIO: ELVN (580K) vs AGIO (48.8M). AGIO has higher revenues than ELVN: AGIO (40.9M) vs ELVN (0).
AGIOELVNAGIO / ELVN
Capitalization2.43B1.21B200%
EBITDA-456.28M-113.93M401%
Gain YTD28.089-8.667-324%
P/E Ratio3.73N/A-
Revenue40.9M0-
Total Cash939M491M191%
Total Debt48.8M580K8,414%
FUNDAMENTALS RATINGS
AGIO: Fundamental Ratings
AGIO
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
85
SMR RATING
1..100
17
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
53
SEASONALITY SCORE
1..100
14

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGIOELVN
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 15 days ago
74%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRSIX27.68N/A
N/A
MFS Research International I
TWIEX14.14N/A
N/A
American Century International Gr Inv
HSUCX33.21N/A
N/A
Rational Dynamic Brands C
ABGNX21.15N/A
N/A
American Century Balanced R5
ALOCX19.53N/A
N/A
Alger Mid Cap Focus C

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with NUVL. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
+0.29%
NUVL - ELVN
54%
Loosely correlated
+0.01%
SYRE - ELVN
52%
Loosely correlated
+0.72%
XNCR - ELVN
52%
Loosely correlated
-7.15%
DNLI - ELVN
52%
Loosely correlated
-0.44%
CRNX - ELVN
51%
Loosely correlated
-0.87%
More